Article
Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.
Arteriosclerosis, thrombosis, and vascular biology - 1 Nov 2017
Lin Yang, Gil Chang-Hyun, Yoder Mervin C
Abstract excerpt
The emergence of induced pluripotent stem cell (iPSC) technology paves the way to generate large numbers of patient-specific endothelial cells (ECs) that can be potentially delivered for regenerative medicine in patients with cardiovascular disease. In the last decade, numerous protocols that differentiate EC from iPSC have been developed by many groups. In this review, we will discuss several common strategies...
Topics
Join the communities discussing this publication.
